Genoway S.A. (ALGEN.PA)
2.95EUR
11 Dec 2009
€0.14 (+4.98%)
€2.81
€2.81
€2.95
€2.81
3,601
6,768
€3.65
€0.84
ALGEN.PA
About
Overall
| Beta: | 0.31 |
| Market Cap (Mil.): | €15.96 |
| Shares Outstanding (Mil.): | 5.68 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| ALGEN.PA | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 12.50 | 4.61 |
| EPS (TTM): | 62.00 | -- | -- |
| ROI: | -- | 1.90 | 2.82 |
| ROE: | -- | 3.07 | 4.12 |
Reuters Summit-UPDATE 1-Rodent maker GenOway eyes profit, cash
* To sign two "significant" deals with drugmakers this year
French and Benelux stocks - Factors to watch on April 6
PARIS, April 6 (Reuters) - Below are leading stories from French and Benelux newspapers and company-related news which could have an impact on the region's markets or individual stocks.
French and Benelux stocks - Factors to watch on April 6
PARIS, April 6 (Reuters) - Below are leading stories from
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
